Advertisement
Patient factors and cancer characteristics are key to deciding between focal therapies and whole gland treatment
Identifying barriers in the renal genetic assessment of Black patients
Belzutifan superior to everolimus in phase 3 clinical trial
Hadley Wood, MD, shares her vision as the new editor-in-chief of Urology
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Novel research to evaluate noninvasive treatments in ED and chronic pelvic pain
Correlation found between the biomarker HSD3B1 and resistance to combined hormone therapy and radiotherapy
Study leverages data from the ROSETTA trial
Findings expand upon earlier data, providing new noninvasive options
Cleveland Clinic is the first to investigate photonic nanoparticles as a potential kidney stone treatment
More on the procedure and the institutional experience
Advertisement
Advertisement